Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-07-15

Clinical Trial Update: Combined Anticholinergic Medication and Sacral Neuromodulation to Treat Refractory Overactive Bladder

View source ↗

Summary

A completed trial evaluating the combination of an anticholinergic medication with sacral neuromodulation for refractory overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anticholinergic medication

Snippet

Sponsor: University of California, Irvine | Conditions: Overactive Bladder | Status: COMPLETED